Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FJEX7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,801
Award facts
- Contract value 100% obligated
- $2,800.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,800.92 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 31, 2025, issued on October 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical contract, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems. The competitively awarded delivery order demonstrates AmerisourceBergen's capability to fulfill federal procurement requirements for specialized pharmaceutical products, in this case the immunosuppressant medication Dupixent for treating conditions such as eczema, asthma, and chronic rhinosinusitis.
Quick answers
Who was awarded contract SPE2DB26FJEX7?
SPE2DB26FJEX7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FJEX7 worth?
The government has obligated $2,801 on SPE2DB26FJEX7.
Is contract SPE2DB26FJEX7 an order under another contract?
Yes. SPE2DB26FJEX7 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB26FJEX7 competed?
The extent of competition for SPE2DB26FJEX7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award